Brief: NeuroOne Successfully Completes Feasibility Study With Its OneRF Ablation System
Dec 6 (Reuters) - NeuroOne Medical Technologies Corp
NMTC.O :
* NEUROONE® SUCCESSFULLY COMPLETES FEASIBILITY STUDY WITH
ITS
ONERF™ ABLATION SYSTEM
* NEUROONE MEDICAL TECHNOLOGIES CORP- COMPANY ON TRACK TO
SUBMIT
ONERF 510(K) APPLICATION TO FDA IN Q2 OF CALENDAR YEAR 2023
Source text for Eikon: ID:nPn8Mv6mZa
Further company coverage: NMTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroone Medical Technologies
See all newsBrief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
NASDAQ RESUMED AT 09:00 AM